100 related articles for article (PubMed ID: 2097537)
1. The blood-brain barrier (BBB) permeability in multiple sclerosis.
Rafałowska J; Krajewski S; Dolińska E
Neuropatol Pol; 1990; 28(1-2):41-54. PubMed ID: 2097537
[No Abstract] [Full Text] [Related]
2. Does damage of perivascular astrocytes in multiple sclerosis plaques participate in blood-brain barrier permeability?
Rafałowska J; Krajewski S; Dolińska E; Dziewulska D
Neuropatol Pol; 1992; 30(1):73-80. PubMed ID: 1484610
[TBL] [Abstract][Full Text] [Related]
3. The blood-brain barrier in cortical multiple sclerosis lesions.
van Horssen J; Brink BP; de Vries HE; van der Valk P; Bø L
J Neuropathol Exp Neurol; 2007 Apr; 66(4):321-8. PubMed ID: 17413323
[TBL] [Abstract][Full Text] [Related]
4. Pathology of multiple sclerosis: some new developments.
Richardson EP
Clin Neurosci; 1994; 2(3-4):253-7. PubMed ID: 7749895
[TBL] [Abstract][Full Text] [Related]
5. Blood-brain barrier changes in multiple sclerosis.
Trojano M; Manzari C; Livrea P
Ital J Neurol Sci; 1992 Dec; 13(9 Suppl 14):55-64. PubMed ID: 1345741
[TBL] [Abstract][Full Text] [Related]
6. Specific central nervous system recruitment of HLA-G(+) regulatory T cells in multiple sclerosis.
Huang YH; Zozulya AL; Weidenfeller C; Metz I; Buck D; Toyka KV; Brück W; Wiendl H
Ann Neurol; 2009 Aug; 66(2):171-83. PubMed ID: 19705413
[TBL] [Abstract][Full Text] [Related]
7. The effects of blood-brain barrier disruption on glial cell function in multiple sclerosis.
McQuaid S; Cunnea P; McMahon J; Fitzgerald U
Biochem Soc Trans; 2009 Feb; 37(Pt 1):329-31. PubMed ID: 19143657
[TBL] [Abstract][Full Text] [Related]
8. The blood-brain-barrier in multiple sclerosis: functional roles and therapeutic targeting.
Correale J; Villa A
Autoimmunity; 2007 Mar; 40(2):148-60. PubMed ID: 17453713
[TBL] [Abstract][Full Text] [Related]
9. Some spaces and barriers in postmortem multiple sclerosis.
Tourtellotte WW; Parker JA
Prog Brain Res; 1968; 29():493-525. PubMed ID: 5735306
[No Abstract] [Full Text] [Related]
10. Magnetic resonance techniques for the in vivo assessment of multiple sclerosis pathology: consensus report of the white matter study group.
Filippi M; Falini A; Arnold DL; Fazekas F; Gonen O; Simon JH; Dousset V; Savoiardo M; Wolinsky JS;
J Magn Reson Imaging; 2005 Jun; 21(6):669-75. PubMed ID: 15906322
[TBL] [Abstract][Full Text] [Related]
11. [Handicap lesions: recent contributions of imaging and neuropathology].
Brochet B
Rev Neurol (Paris); 2008 Apr; 164 Spec No 2():F131-7. PubMed ID: 18680831
[No Abstract] [Full Text] [Related]
12. Pathology of multiple sclerosis.
Seitelberger F
Ann Clin Res; 1973 Oct; 5(5):337-44. PubMed ID: 4792208
[No Abstract] [Full Text] [Related]
13. Blood-brain barrier alterations in both focal and diffuse abnormalities on postmortem MRI in multiple sclerosis.
Vos CM; Geurts JJ; Montagne L; van Haastert ES; Bö L; van der Valk P; Barkhof F; de Vries HE
Neurobiol Dis; 2005 Dec; 20(3):953-60. PubMed ID: 16039866
[TBL] [Abstract][Full Text] [Related]
14. A dynamic view of the blood-brain barrier in active multiple sclerosis lesions.
Lassmann H
Ann Neurol; 2011 Jul; 70(1):1-2. PubMed ID: 21710628
[No Abstract] [Full Text] [Related]
15. [Disorders in the function of the blood-brain barrier in multiple sclerosis].
Sachs B; Zimmermann K
Z Arztl Fortbild (Jena); 1981 Oct; 75(19):889-91. PubMed ID: 7314678
[No Abstract] [Full Text] [Related]
16. [The pathogenesis of multiple sclerosis].
Kesselring J
Schweiz Med Wochenschr; 1990 Jul; 120(30):1083-90. PubMed ID: 2203139
[TBL] [Abstract][Full Text] [Related]
17. Acute tumefactive demyelinating lesions in a pediatric patient with known diagnosis of multiple sclerosis: review of the literature and treatment proposal.
Dastgir J; DiMario FJ
J Child Neurol; 2009 Apr; 24(4):431-7. PubMed ID: 19189932
[TBL] [Abstract][Full Text] [Related]
18. Meningeal inflammation is not associated with cortical demyelination in chronic multiple sclerosis.
Kooi EJ; Geurts JJ; van Horssen J; Bø L; van der Valk P
J Neuropathol Exp Neurol; 2009 Sep; 68(9):1021-8. PubMed ID: 19680141
[TBL] [Abstract][Full Text] [Related]
19. Statins reduce human blood-brain barrier permeability and restrict leukocyte migration: relevance to multiple sclerosis.
Ifergan I; Wosik K; Cayrol R; Kébir H; Auger C; Bernard M; Bouthillier A; Moumdjian R; Duquette P; Prat A
Ann Neurol; 2006 Jul; 60(1):45-55. PubMed ID: 16729291
[TBL] [Abstract][Full Text] [Related]
20. Ultrastructural studies of multiple sclerosis.
Suzuki K; Andrews JM; Waltz JM; Terry RD
Lab Invest; 1969 May; 20(5):444-54. PubMed ID: 5767418
[No Abstract] [Full Text] [Related]
[Next] [New Search]
